Top Antibiotics Exporting Countries & Companies Overview in 2024 - Tendata

In 2024, worldwide antibiotics exports generated approximately US$10.52 billion in international sales. Compared with US$9.96 billion in 2020, the total value of exported antibiotics increased by about 5.6% over a five-year period. On a yearly basis, global antibiotics trade showed only marginal growth, edging up 0.5% from US$10.46 billion in 2023.

Classified within organic chemical products, antibiotics are pharmaceutical substances used to treat and prevent bacterial infections. They are ineffective against viral illnesses such as influenza or the common cold, meaning they are not considered antiviral medications.

The world’s most influential antibiotics suppliers in 2024 were mainland China, India, Switzerland, Italy, and the United States, which together accounted for roughly 74.6% of global antibiotic export value.

Regionally, Asia dominated the antibiotics export market with shipments worth US$5.8 billion, representing 55.4% of the global total. Europe followed with 34.6%. Smaller shares came from North America (7.4%), Latin America excluding Mexico but including the Caribbean (2.5%), Oceania (0.1%)—primarily Australia and New Zealand—and Africa (0.02%).

For classification purposes, antibiotics fall under the 4-digit Harmonized System code prefix 2609.

Top Antibiotics Exporters by Country

Below are the 20 countries that recorded the highest value of antibiotics exports in 2024, along with their respective shares of global shipments:

· Mainland China: US$4.3 billion (41%)

· India: US$1.1 billion (10.2%)

· Switzerland: US$867.4 million (8.2%)

· Italy: US$854.5 million (8.1%)

· United States: US$736.5 million (7%)

· Belgium: US$489.1 million (4.7%)

· Spain: US$408.2 million (3.9%)

· Panama: US$205.2 million (2%)

· Denmark: US$187.6 million (1.8%)

· South Korea: US$173 million (1.6%)

· France: US$127.9 million (1.2%)

· Netherlands: US$114.2 million (1.1%)

· Austria: US$99.4 million (0.9%)

· Germany: US$98.7 million (0.9%)

· Singapore: US$94.4 million (0.9%)

· Hungary: US$88 million (0.8%)

· Japan: US$86.8 million (0.8%)

· Ireland: US$63.8 million (0.6%)

· Brazil: US$57 million (0.5%)

· Portugal: US$41.5 million (0.4%)

Together, these 20 countries represented 96.8% of total global antibiotics export revenue in 2024.

Growth Trends Among Exporters

The fastest-expanding antibiotics exporters from 2023 to 2024 included Ireland (+83.5%), Belgium (+17.8%), Switzerland (+15.7%), and Germany (+10.6%).

Conversely, some exporters recorded notable declines, particularly Singapore (-41.3%), the United States (-31.7%), Portugal (-22.9%), and Hungary (-16.5%).

Major Antibiotics Exporting Companies

Based on Tendata global trade data platform, the following companies ranked among the leading antibiotics exporters in 2024:

1. ООО НПФ МАТЕРИА МЕДИКА ХОЛДИНГ (10.11%, US$18.03 million)

2. VITALIS S A C I (5.41%, US$9.64 million)

3. MEDLOG COTE D IVOIRE S A (4.46%, US$7.95 million)

4. ООО ДЖОНСОН AND ДЖОНСОН (4.29%, US$7.66 million)

5. АО НИЖФАРМ (3.71%, US$6.62 million)

6. АО ВАЛЕНТА ФАРМ (3.52%, US$6.28 million)

7. VALLECILLA B Y VALLECILLA M Y CIA S C A CARVAL DE COLOMBIA (3.45%, US$6.16 million)

8. LABORATORIOS LA SANTE S A (3.27%, US$5.84 million)

9. FANAN ET MAMADOU GENERAL SERVICES (3.26%, US$5.82 million)

10. ПАТ НВЦ БОРЩАГІВСЬКИЙ ХФЗ (2.8%, US$5 million)

This overview highlights the competitive landscape of global antibiotics exports and the countries and companies shaping international supply chains in 2024.